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background:  GISSI prevention trial demonstrated that long term assumption of omega-3 fatty acids improves significantly the prognosis 
of patients with a history of myocardial infarction (MI), mainly due to anti-arrhythmic effects. However, the acute effect of omega-3 fatty acids 
especially on arrhythmic events in patients undergoing percutaneous coronary intervention (PCI) during admission remains unknown.
methods: Consecutive 115 patients with acute MI (95 STEMI patients and 20 non-STEMI patients) were randomized to the eicosapentaenoic acid 
(EPA) arm (EPA 1800 mg/day + pitavastaitn 2mg/day, orally) or the control arm (pitavastaitn 2mg/day alone, orally) just after successful PCI. The 
primary endpoint was in-hospital events including death, nonfatal MI, stroke, malignant ventricular arrhythmia, paroxysmal atrial fibrillation and 
prolongation of hospitalization over 30 days. Serum CRP levels were measured on admission and 2-14 days after PCI.
results:  There were no differences in baseline risk factors including levels of omega-3 and omega-6 fatty acids between the groups. In-hospital 
events were observed more frequently in the control arm than those in the EPA arm (31.0% vs. 10.5%, p<0.01). Among in-hospital events, malignant 
ventricular arrhythmia occurred more in the control arm than in the EPA arm (24.1% vs. 7.0%, p<0.05). The max CK-MB were comparable between 
two groups; however, CRP peak levels at the day4 after PCI in the EPA group were significantly lower than that in the control group (7.8 ± 3.2 vs 
10.4 ± 4.3 mg/l, p<0.01). Left ventricular end-diastolic volume did not differ between two arms around 30 days after PCI. Multiivariable analysis 
including age, gender, conventional risk factors, target vessel and STEMI or non-STEMI showed that EPA treatment was independently associated with 
a decreased risk of in-hospital events (odds ratios 0.210, 95% CI 0.072 to 0.614, p<0.01).
Conclusions:  Early loading of omega-3 fatty acids decreased in-hospital arrhythmic events in patients with acute MI undergoing PCI; anti-
inflammatory effects may be involved in this anti-arrhythmic effect. These results lend further support to early use of omega-3 fatty acids as adjuvant 
therapy.
